Yakov Datsenko

Yakov Datsenko is a highly experienced professional in clinical development operations, currently serving as Sr. Clinical Development Operations Lead for the Inflammation Therapeutic Area at Boehringer Ingelheim since March 2011. Datsenko has a proven track record in overseeing clinical delivery for inflammatory bowel disease programs, leading teams, and managing organizational structures within the Clinical Development Operations. Previous roles include Project Leader and Medical Advisor at PharmaProjekthaus GmbH & Co. KG and Project Manager for Clinical Trials at Health Research Services Ltd. Datsenko also has a strong foundation in medicine, with an M.D. from Bogomolets National Medical University and recent executive education from Harvard Medical School.